Ontruzant is a specialty medication, which means it's costly and requires more steps than usual in order to get it. We break down the process for you.
About Ontruzant
Ontruzant (trastuzumab-dttb) is used to treat stomach and breast cancer. Ontruzant is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Ontruzant may be covered by your Medicare or insurance plan.
With the Patient Assistance Program from Genentech, you can receive your medication at no cost.